AstraZeneca's Dobber On Ramping In Renal, Expanding In CV And Business Development

 
• By Jessica Merrill

Biopharmaceuticals President Ruud Dobber talked to Scrip about the launches of Lokelma and roxadustat in kidney disease, building with a high bar in cardiovascular disease and expanding in cell and gene therapy.

Ruud Dobber
AstraZeneca's Dobber talked to Scrip at J.P. Morgan • Source: AstraZeneca

More from Strategy

More from Business